AGIO Stock: Agios Pharmaceuticals, Inc. Stock Price, Analysis & Insights
Get live agio stock price $23.61, comprehensive Agios Pharmaceuticals, Inc. stock analysis, charts, news, and expert forecast. Real-time agio stock data and investment insights.
Loading chart...
Company Overview
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Company Information
- CEO
- Brian M. Goff
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 486
Contact Information
- Website
- https://www.agios.com
- Address
- 88 Sidney Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Agios Pharmaceuticals, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Brian M. Goff, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Agios Pharmaceuticals, Inc. competes in the Biotechnology within the broader Healthcare. With 1.4 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Agios Pharmaceuticals, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Agios Pharmaceuticals, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Agios Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Agios Pharmaceuticals, Inc.
- ⚠Investors should consider how Agios Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.38B
P/E Ratio
-3.37
Beta
0.84
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 1.38B market capitalization
- Trading Volume: 9.18M shares traded today
- Price Range: 52-week range of $22.35 - $62.45
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. (AGIO) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 1.38B, the company represents a significant player in its market. The stock is currently trading at $23.61 with a negativedaily change of 48.10%.
The company's 486 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -3.37, beta of 0.84, and 52-week price range from $22.35 to $62.45when evaluating investment opportunities.
Why Invest in Agios Pharmaceuticals, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Brian M. Goff
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.